Showing 1 - 12 of 69 results for "03805"
1 Product
- ReferenceJ. L. Nieto-Torres et al. (jul 2011) Virology 415 2 69--82
Subcellular location and topology of severe acute respiratory syndrome coronavirus envelope protein.
Severe acute respiratory syndrome (SARS) coronavirus (CoV) envelope (E) protein is a transmembrane protein. Several subcellular locations and topological conformations of E protein have been proposed. To identify the correct ones, polyclonal and monoclonal antibodies specific for the amino or the carboxy terminus of E protein, respectively, were generated. E protein was mainly found in the endoplasmic reticulum-Golgi intermediate compartment (ERGIC) of cells transfected with a plasmid encoding E protein or infected with SARS-CoV. No evidence of E protein presence in the plasma membrane was found by using immunofluorescence, immunoelectron microscopy and cell surface protein labeling. In addition, measurement of plasma membrane voltage gated ion channel activity by whole-cell patch clamp suggested that E protein was not present in the plasma membrane. A topological conformation in which SARS-CoV E protein amino terminus is oriented towards the lumen of intracellular membranes and carboxy terminus faces cell cytoplasm is proposed. View PublicationCatalog #: Product Name: 03805 ClonaCell™-HY Medium E Catalog #: 03805 Product Name: ClonaCell™-HY Medium E - ReferenceS. Bangaru et al. (may 2019) Cell 177 5 1136--1152.e18
A Site of Vulnerability on the Influenza Virus Hemagglutinin Head Domain Trimer Interface.
Here, we describe the discovery of a naturally occurring human antibody (Ab), FluA-20, that recognizes a new site of vulnerability on the hemagglutinin (HA) head domain and reacts with most influenza A viruses. Structural characterization of FluA-20 with H1 and H3 head domains revealed a novel epitope in the HA trimer interface, suggesting previously unrecognized dynamic features of the trimeric HA protein. The critical HA residues recognized by FluA-20 remain conserved across most subtypes of influenza A viruses, which explains the Ab's extraordinary breadth. The Ab rapidly disrupted the integrity of HA protein trimers, inhibited cell-to-cell spread of virus in culture, and protected mice against challenge with viruses of H1N1, H3N2, H5N1, or H7N9 subtypes when used as prophylaxis or therapy. The FluA-20 Ab has uncovered an exceedingly conserved protective determinant in the influenza HA head domain trimer interface that is an unexpected new target for anti-influenza therapeutics and vaccines. View PublicationCatalog #: Product Name: 03801 ClonaCell™-HY Medium A 03805 ClonaCell™-HY Medium E 19055 EasySep™ Human NK Cell Enrichment Kit Catalog #: 03801 Product Name: ClonaCell™-HY Medium A Catalog #: 03805 Product Name: ClonaCell™-HY Medium E Catalog #: 19055 Product Name: EasySep™ Human NK Cell Enrichment Kit - ReferenceSapparapu G et al. (NOV 2016) Nature
Neutralizing human antibodies prevent Zika virus replication and fetal disease in mice.
Zika virus (ZIKV) is an emerging mosquito-transmitted flavivirus that can cause severe disease, including congenital birth defects during pregnancy(1). To develop candidate therapeutic agents against ZIKV, we isolated a panel of human monoclonal antibodies (mAbs) from subjects with prior ZIKV infection. A subset of mAbs recognized diverse epitopes on the envelope (E) protein and exhibited potently neutralizing activity. One of the most inhibitory mAbs, ZIKV-117, broadly neutralized infection of ZIKV strains corresponding to African, Asian, and American lineages. Epitope mapping studies revealed that ZIKV-117 recognized a unique quaternary epitope on the E protein dimer-dimer interface. We evaluated the therapeutic efficacy of ZIKV-117 in pregnant and non-pregnant mice. mAb treatment markedly reduced tissue pathology, placental and fetal infection, and mortality in mice. Thus, neutralizing human mAbs can protect against maternal-fetal transmission, infection and disease, and reveal important determinants for structure-based rational vaccine design efforts. View PublicationCatalog #: Product Name: 03800 ClonaCell™-HY Hybridoma Kit Catalog #: 03800 Product Name: ClonaCell™-HY Hybridoma Kit - ReferenceMousa JJ et al. (OCT 2016) Proceedings of the National Academy of Sciences of the United States of America Oct 17 201609449
Structural basis for nonneutralizing antibody competition at antigenic site II of the respiratory syncytial virus fusion protein.
Palivizumab was the first antiviral monoclonal antibody (mAb) approved for therapeutic use in humans, and remains a prophylactic treatment for infants at risk for severe disease because of respiratory syncytial virus (RSV). Palivizumab is an engineered humanized version of a murine mAb targeting antigenic site II of the RSV fusion (F) protein, a key target in vaccine development. There are limited reported naturally occurring human mAbs to site II; therefore, the structural basis for human antibody recognition of this major antigenic site is poorly understood. Here, we describe a nonneutralizing class of site II-specific mAbs that competed for binding with palivizumab to postfusion RSV F protein. We also describe two classes of site II-specific neutralizing mAbs, one of which escaped competition with nonneutralizing mAbs. An X-ray crystal structure of the neutralizing mAb 14N4 in complex with F protein showed that the binding angle at which human neutralizing mAbs interact with antigenic site II determines whether or not nonneutralizing antibodies compete with their binding. Fine-mapping studies determined that nonneutralizing mAbs that interfere with binding of neutralizing mAbs recognize site II with a pose that facilitates binding to an epitope containing F surface residues on a neighboring protomer. Neutralizing antibodies, like motavizumab and a new mAb designated 3J20 that escape interference by the inhibiting mAbs, avoid such contact by binding at an angle that is shifted away from the nonneutralizing site. Furthermore, binding to rationally and computationally designed site II helix-loop-helix epitope-scaffold vaccines distinguished neutralizing from nonneutralizing site II antibodies. View PublicationCatalog #: Product Name: 03800 ClonaCell™-HY Hybridoma Kit Catalog #: 03800 Product Name: ClonaCell™-HY Hybridoma Kit - ReferenceWilson JR et al. (NOV 2016) Antiviral Research 135 48--55
An influenza A virus (H7N9) anti-neuraminidase monoclonal antibody with prophylactic and therapeutic activity in vivo
Zoonotic A(H7N9) avian influenza viruses emerged in China in 2013 and continue to be a threat to human public health, having infected over 800 individuals with a mortality rate approaching 40%. Treatment options for people infected with A(H7N9) include the use of neuraminidase (NA) inhibitors. However, like other influenza viruses, A(H7N9) can become resistant to these drugs. The use of monoclonal antibodies is a rapidly developing strategy for controlling influenza virus infection. Here we generated a murine monoclonal antibody (3c10-3) directed against the NA of A(H7N9) and show that prophylactic systemic administration of 3c10-3 fully protected mice from lethal challenge with wild-type A/Anhui/1/2013 (H7N9). Further, post-infection treatment with a single systemic dose of 3c10-3 at either 24, 48 or 72 h post A(H7N9) challenge resulted in both dose- and time-dependent protection of up to 100% of mice, demonstrating therapeutic potential for 3c10-3. Epitope mapping revealed that 3c10-3 binds near the enzyme active site of NA, and functional characterization showed that 3c10-3 inhibits the enzyme activity of NA and restricts the cell-to-cell spread of the virus in cultured cells. Affinity analysis also revealed that 3c10-3 binds equally well to recombinant NA of wild-type A/Anhui/1/2013 and to a variant NA carrying a R289K mutation known to infer NAI resistance. These results suggest that 3c10-3 has the potential to be used as a therapeutic to treat A(H7N9) infections either as an alternative to, or in combination with, current NA antiviral inhibitors. View PublicationCatalog #: Product Name: 03800 ClonaCell™-HY Hybridoma Kit Catalog #: 03800 Product Name: ClonaCell™-HY Hybridoma Kit - ReferenceKanzaki H et al. ( 2016) Scientific Reports 6 August 32259
A-Disintegrin and Metalloproteinase (ADAM) 17 enzymatically degrades interferon-gamma
Catalog #: Product Name: 03800 ClonaCell™-HY Hybridoma Kit Catalog #: 03800 Product Name: ClonaCell™-HY Hybridoma Kit - ReferenceAlvarado G and Crowe JE ( 2016) 1442 63--76
Development of human monoclonal antibodies against respiratory syncytial virus using a high efficiency human hybridoma technique.
Human monoclonal antibodies against RSV have high potential for use as prophylaxis or therapeutic molecules, and they also can be used to define the structure of protective epitopes for rational vaccine design. In the past, however, isolation of human monoclonal antibodies was difficult and inefficient. Here, we describe contemporary methods for activation and proliferation of primary human memory B cells followed by cytofusion to non-secreting myeloma cells by dielectrophoresis to generate human hybridomas secreting RSV-specific monoclonal antibodies. We also provide experimental methods for screening human B cell lines to obtain RSV-specific lines, especially lines secreting neutralizing antibodies. View PublicationCatalog #: Product Name: 03800 ClonaCell™-HY Hybridoma Kit Catalog #: 03800 Product Name: ClonaCell™-HY Hybridoma Kit - ReferenceLee WT et al. (DEC 2016) Developmental & Comparative Immunology 65 114--123
Identification of secreted and membrane-bound bat immunoglobulin using a Microchiropteran-specific mouse monoclonal antibody
Bat immunity has received increasing attention because some bat species are being decimated by the fungal disease, White Nose Syndrome, while other species are potential reservoirs of zoonotic viruses. Identifying specific immune processes requires new specific tools and reagents. In this study, we describe a new mouse monoclonal antibody (mAb) reactive with Eptesicus fuscus immunoglobulins. The epitope recognized by mAb BT1-4F10 was localized to immunoglobulin light (lambda) chains; hence, the mAb recognized serum immunoglobulins and B lymphocytes. The BT1-4F10 epitope appeared to be restricted to Microchiropteran immunoglobulins and absent from Megachiropteran immunoglobulins. Analyses of sera and other E. fuscus fluids showed that most, if not all, secreted immunoglobulins utilized lambda light chains. Finally, mAb BT1-4F10 permitted the identification of B cell follicles in splenic white pulp. This Microchiropteran-specific mAb has potential utility in seroassays; hence, this reagent may have both basic and practical applications for studying immune process. View PublicationCatalog #: Product Name: 03800 ClonaCell™-HY Hybridoma Kit Catalog #: 03800 Product Name: ClonaCell™-HY Hybridoma Kit - ReferenceYew CW and Tan YJ ( 2016) 1426 225--33
Generation of mouse monoclonal antibodies specific to Chikungunya virus using ClonaCell-HY hybridoma cloning kit
Monoclonal antibodies offer high specificity and this makes it an important tool for molecular biology, biochemistry and medicine. Typically, monoclonal antibodies are generated by fusing mouse spleen cells that have been immunized with the desired antigen with myeloma cells to create immortalized hybridomas. Here, we describe the generation of monoclonal antibodies that are specific to Chikungunya virus using ClonaCell-HY system. View PublicationCatalog #: Product Name: 03800 ClonaCell™-HY Hybridoma Kit Catalog #: 03800 Product Name: ClonaCell™-HY Hybridoma Kit - ReferenceKaabinejadian S et al. (MAY 2016) The Journal of Immunology 196 10 4263--73
Immunodominant West Nile virus T cell epitopes are fewer in number and fashionably late
Class I HLA molecules mark infected cells for immune targeting by presenting pathogen-encoded peptides on the cell surface. Characterization of viral peptides unique to infected cells is important for understanding CD8(+) T cell responses and for the development of T cell-based immunotherapies. Having previously reported a series of West Nile virus (WNV) epitopes that are naturally presented by HLA-A*02:01, in this study we generated TCR mimic (TCRm) mAbs to three of these peptide/HLA complexes-the immunodominant SVG9 (E protein), the subdominant SLF9 (NS4B protein), and the immunorecessive YTM9 (NS3 protein)-and used these TCRm mAbs to stain WNV-infected cell lines and primary APCs. TCRm staining of WNV-infected cells demonstrated that the immunorecessive YTM9 appeared several hours earlier and at 5- to 10-fold greater density than the more immunogenic SLF9 and SVG9 ligands, respectively. Moreover, staining following inhibition of the TAP demonstrated that all three viral ligands were presented in a TAP-dependent manner despite originating from different cellular compartments. To our knowledge, this study represents the first use of TCRm mAbs to define the kinetics and magnitude of HLA presentation for a series of epitopes encoded by one virus, and the results depict a pattern whereby individual epitopes differ considerably in abundance and availability. The observations that immunodominant ligands can be found at lower levels and at later time points after infection suggest that a reevaluation of the factors that combine to shape T cell reactivity may be warranted. View PublicationCatalog #: Product Name: 03800 ClonaCell™-HY Hybridoma Kit Catalog #: 03800 Product Name: ClonaCell™-HY Hybridoma Kit - ReferenceCindric Vranesic A et al. (MAY 2016) Human Molecular Genetics May 11 ddw140
Characterization of SKAP/kinastrin isoforms: the N-terminus defines tissue specificity and Pontin binding
Small Kinetochore-Associated Protein (SKAP)/Kinastrin is a multifunctional protein with proposed roles in mitosis, apoptosis and cell migration. Exact mechanisms underlying its activities in these cellular processes are not completely understood. SKAP is predicted to have different isoforms, however, previous studies did not differentiate between them. Since distinct molecular architectures of protein isoforms often influence their localization and functions, this study aimed to examine the expression profile and functional differences between SKAP isoforms in human and mouse. Analyses of various human tissues and cells of different origin by RT-PCR, and by Western blotting and immunocytochemistry applying newly generated anti-SKAP monoclonal antibodies revealed that human SKAP exists in two protein isoforms: ubiquitously expressed SKAP16 and testis/sperm-specific SKAP1. In mouse, SKAP1 expression is detectable in testis at 4 weeks postnatally, when the first wave of spermatogenesis in mice is complete and the elongated spermatids are present in the testes. Furthermore, we identified Pontin as a new SKAP1 interaction partner. SKAP1 and Pontin co-localized in the flagellar region of human sperm suggesting a functional relevance for SKAP1-Pontin interaction in sperm motility. Since most previous studies on SKAP were performed with the testis-specific isoform SKAP1, our findings provide a new basis for future studies on the role of SKAP in both human somatic cells and male germ cells, including studies on male fertility. View PublicationCatalog #: Product Name: 03800 ClonaCell™-HY Hybridoma Kit Catalog #: 03800 Product Name: ClonaCell™-HY Hybridoma Kit - ReferenceSun Y et al. (MAY 2016) mBio 7 2 e00465--16
Deletion of a Yci1 Domain Protein of Candida albicans Allows Homothallic Mating in MTL Heterozygous Cells
It has been proposed that the ancestral fungus was mating competent and homothallic. However, many mating-competent fungi were initially classified as asexual because their mating capacity was hidden behind layers of regulation. For efficient in vitro mating, the essentially obligate diploid ascomycete pathogen Candida albicans has to change its mating type locus from heterozygous MTL a /α to homozygous MTL a / a or MTL α/α and then undergo an environmentally controlled epigenetic switch to the mating-competent opaque form. These requirements greatly reduce the potential for C. albicans mating. Deletion of the Yci1 domain gene OFR1 bypasses the need for C. albicans cells to change the mating type locus from heterozygous to homozygous prior to switching to the opaque form and mating and allows homothallic mating of MTL heterozygous strains. This bypass is carbon source dependent and does not occur when cells are grown on glucose. Transcriptional profiling of ofr1 mutant cells shows that in addition to regulating cell type and mating circuitry, Ofr1 is needed for proper regulation of histone and chitin biosynthesis gene expression. It appears that OFR1 is a key regulator in C. albicans and functions in part to maintain the cryptic mating phenotype of the pathogen. View PublicationCatalog #: Product Name: 03800 ClonaCell™-HY Hybridoma Kit Catalog #: 03800 Product Name: ClonaCell™-HY Hybridoma Kit
1 Product
Shop By
Filter Results
Filters:
- Resource Type Reference Remove This Item
- Clear All
- Area of Interest
-
- Cancer 12 items
- Cell Line Development 67 items
- Drug Discovery and Toxicity Testing 54 items
- Epithelial Cell Biology 1 item
- HLA 3 items
- Immunology 17 items
- Neuroscience 2 items
- Transplantation Research 1 item
- Brand
-
- ClonaCell 68 items
- EasyPick 1 item
- EasySep 1 item
- MethoCult 1 item
- MyeloCult 1 item
- RosetteSep 2 items
- Cell Type
-
- B Cells 4 items
- Cancer Cells and Cell Lines 9 items
- Dendritic Cells 2 items
- Epithelial Cells 1 item
- Hybridomas 66 items
- Mammary Cells 1 item
- Monocytes 1 item
- Myeloid Cells 1 item
- NK Cells 2 items
- Neurons 1 item
- T Cells 4 items
- T Cells, CD4+ 1 item
- T Cells, CD8+ 2 items